Glynore Pharma Private Limited
About Glynore Pharma Private Limited
Data last updated:
Glynore Pharma Private Limited is a private limited company based in Ludhiana, Punjab, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 September 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2000PTC023961. Its GSTIN is 03AABCG5649P1Z9 (Punjab).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹24 Lakh. It is led by directors Amritpal Singh and Harsimran Kaur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ludhiana, Punjab.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.64 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹15.14 Lakh (net margin 2%) and EBITDA of ₹65.11 Lakh (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 79% over three years and 27% over five years.
As per MCA filings, the company has open charges of ₹6.04 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address10 – 12 Liberty Enclave, Pakhowal Road Vill. Dad, Ludhiana, Punjab, India – 142022
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Glynore Pharma Private Limited
The main business activity of Glynore Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Glynore Pharma Private Limited FY 2025 filings available
Glynore Pharma Private Limited reported revenue of ₹7.64 Cr (up 40% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Glynore Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 40% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Glynore Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹65.11 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹15.14 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Glynore Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Glynore Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Glynore Pharma Private Limited
Glynore Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sasvat Omnicare Private Limited | ₹7.71 Cr (FY 2024) | •••• | •••• | -73.0% | •••• | Bangalore, Karnataka, India |
| Rebrace Pharmaceuticals Private Limited | ₹7.71 Cr (FY 2024) | •••• | •••• | 55.0% | •••• | Bishnupur, West Bengal, India |
| Ridhi Sidhi Medicos Private Limited | ₹7.69 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Lucknow, Uttar Pradesh, India |
| Dwarika Leela & Sons Private Limited | ₹7.69 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Chandauli, Uttar Pradesh, India |
| Matrix Pharma-Chem (India) Private Limited | ₹7.67 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Secunderabad, Telangana, India |
| Glynore Pharma Private Limited this company | ₹7.64 Cr (FY 2025) | •••• | •••• | 40.0% | •••• | Ludhiana, Punjab, India |
| Globax India Bio Pharmaceutical Private Limited | ₹7.64 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Noida, Uttar Pradesh, India |
| Esteve Pharma Limited | ₹7.63 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | Dehradun, Uttarakhand, India |
| Space Health Care Private Limited | ₹7.62 Cr (FY 2025) | •••• | •••• | 54.0% | •••• | Indore, Madhya Pradesh, India |
| Almaa Herbal Nature Private Limited | ₹7.62 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Chennai, Tamil Nadu, India |
| Cubic Lifesciences Private Limited | ₹7.59 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Glynore Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Glynore Pharma Private Limited
Glynore Pharma Private Limited is audited by M.S. CHANDOK & COMPANY for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M.S. CHANDOK & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Glynore Pharma Private Limited
Glynore Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amritpal Singh | Director | 15 Sep 2000 | 26 Years 0 Months | Current |
| Harsimran Kaur Also directs: DS Cosmeceuticals Private Limited | Director | 14 Dec 2015 | 10 Years 9 Months | Current |
Ownership and Shareholding of Glynore Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Glynore Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Aug 2023 | Hdfc Bank Limited | ₹15.48 Lakh | Open |
| 10 Nov 2020 | Hdfc Bank Limited | ₹25.08 Lakh | Open |
| 26 Dec 2016 | Hdfc Bank Limited | ₹2.48 Cr | Open |
| 30 Apr 2015 | Hdb Financial Services Limited | ₹1.25 Cr | Open |
| 16 Apr 2005 | Centurian Bank Limited | ₹30 Lakh | Open |
Total charge records: 7 View all charges
Legal Cases of Glynore Pharma Private Limited
Glynore Pharma Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Cadila Pharmaceutical Limited | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Glynore Pharma Private Limited
Employment history and EPFO contributions of people linked to Glynore Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Glynore Pharma Private Limited
Glynore Pharma Private Limited has 4 board changes on record since 2000: 3 appointments and 1 cessation. The latest: Parvinder Kaur ceased to be Director on 16 Dec 2015.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Glynore Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Glynore Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Glynore Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Glynore Pharma Private Limited
Glynore Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AABCG5649P1Z9 | Punjab | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Glynore Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glynore Pharma Private Limited
Glynore Pharma is an active private limited company based in Ludhiana, Punjab, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 September 2000 (26+ years old) and is registered under CIN U24232PB2000PTC023961.
Glynore Pharma reported revenue of ₹7.64 Cr for FY 2025 (up 40% YoY).
Glynore Pharma has 2 current directors:
- Amritpal Singh - Director
- Harsimran Kaur - Director
Glynore Pharma reported a net profit of ₹15.14 Lakh (net margin 2%) and EBITDA of ₹65.11 Lakh (EBITDA margin 8.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Glynore Pharma is 79% over three years and 27% over five years. In the latest year (FY 2025) revenue rose 40%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Glynore Pharma is 03AABCG5649P1Z9, registered in Punjab.
The CIN (Corporate Identification Number) of Glynore Pharma is U24232PB2000PTC023961. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glynore Pharma has 1 court case on record: 1 filed against it.
Glynore Pharma was incorporated on 15 September 2000, making it 26+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Glynore Pharma by revenue are Sasvat Omnicare Private Limited, Rebrace Pharmaceuticals Private Limited, Ridhi Sidhi Medicos Private Limited, Dwarika Leela & Sons Private Limited, Matrix Pharma-Chem (India) Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Parvinder Kaur ceased to be Director on 16 Dec 2015. Harsimran Kaur was appointed as Director on 14 Dec 2015. Amritpal Singh was appointed as Director on 15 Sep 2000. Glynore Pharma has 4 board changes on record in total.